Global Gengnian An Tablets Market Growth 2026-2032

January 2026 | 123 pages | ID: G1CE44EF946EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Gengnian An Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Gengnian An Tablets nourish yin, clear away heat, relieve restlessness and calm the mind. They are used to treat hot flashes, sweating, dizziness, tinnitus, insomnia, irritability, unstable blood pressure and other symptoms during menopause.

United States market for Gengnian An Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Gengnian An Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Gengnian An Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Gengnian An Tablets players cover Lanzhou Taibao Pharmaceutical Co., Ltd., Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd., Tianjin Medicine Darentang Group Co., Ltd., Xi'an Zili Chinese Medicine Group Co., Ltd., Jiangxi Jimin Kexin Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Gengnian An Tablets Industry Forecast” looks at past sales and reviews total world Gengnian An Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Gengnian An Tablets sales for 2026 through 2032. With Gengnian An Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gengnian An Tablets industry.

This Insight Report provides a comprehensive analysis of the global Gengnian An Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gengnian An Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gengnian An Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gengnian An Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gengnian An Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Gengnian An Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Sugar-coated Tablets
  • Non-sugar-coated Tablets
Segmentation by Application:
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Lanzhou Taibao Pharmaceutical Co., Ltd.
  • Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd.
  • Tianjin Medicine Darentang Group Co., Ltd.
  • Xi'an Zili Chinese Medicine Group Co., Ltd.
  • Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  • Yabao Pharmaceutical Group Co., Ltd.
  • Guilong Pharmaceutical (Anhui) Co., Ltd.
  • Jilin Zixin Pharmaceutical Co., Ltd.
  • Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd.
  • Guangxi Jinhaitang Pharmaceutical Co., Ltd.
  • Shanxi Zhendong Pharmaceutical Co., Ltd.
  • China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  • Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Gengnian An Tablets market?
  • What factors are driving Gengnian An Tablets market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Gengnian An Tablets market opportunities vary by end market size?
  • How does Gengnian An Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gengnian An Tablets Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Gengnian An Tablets by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Gengnian An Tablets by Country/Region, 2021, 2025 & 2032
2.2 Gengnian An Tablets Segment by Type
  2.2.1 Sugar-coated Tablets
  2.2.2 Non-sugar-coated Tablets
  2.2.3 Gengnian An Tablets Sales by Type
    2.2.3.1 Global Gengnian An Tablets Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Gengnian An Tablets Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Gengnian An Tablets Sale Price by Type (2021-2026)
2.3 Gengnian An Tablets Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Gengnian An Tablets Sales by Application
    2.3.4.1 Global Gengnian An Tablets Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Gengnian An Tablets Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Gengnian An Tablets Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Gengnian An Tablets Breakdown Data by Company
  3.1.1 Global Gengnian An Tablets Annual Sales by Company (2021-2026)
  3.1.2 Global Gengnian An Tablets Sales Market Share by Company (2021-2026)
3.2 Global Gengnian An Tablets Annual Revenue by Company (2021-2026)
  3.2.1 Global Gengnian An Tablets Revenue by Company (2021-2026)
  3.2.2 Global Gengnian An Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Gengnian An Tablets Sale Price by Company
3.4 Key Manufacturers Gengnian An Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Gengnian An Tablets Product Location Distribution
  3.4.2 Players Gengnian An Tablets Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR GENGNIAN AN TABLETS BY GEOGRAPHIC REGION

4.1 World Historic Gengnian An Tablets Market Size by Geographic Region (2021-2026)
  4.1.1 Global Gengnian An Tablets Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Gengnian An Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Gengnian An Tablets Market Size by Country/Region (2021-2026)
  4.2.1 Global Gengnian An Tablets Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Gengnian An Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Gengnian An Tablets Sales Growth
4.4 APAC Gengnian An Tablets Sales Growth
4.5 Europe Gengnian An Tablets Sales Growth
4.6 Middle East & Africa Gengnian An Tablets Sales Growth

5 AMERICAS

5.1 Americas Gengnian An Tablets Sales by Country
  5.1.1 Americas Gengnian An Tablets Sales by Country (2021-2026)
  5.1.2 Americas Gengnian An Tablets Revenue by Country (2021-2026)
5.2 Americas Gengnian An Tablets Sales by Type (2021-2026)
5.3 Americas Gengnian An Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gengnian An Tablets Sales by Region
  6.1.1 APAC Gengnian An Tablets Sales by Region (2021-2026)
  6.1.2 APAC Gengnian An Tablets Revenue by Region (2021-2026)
6.2 APAC Gengnian An Tablets Sales by Type (2021-2026)
6.3 APAC Gengnian An Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Gengnian An Tablets by Country
  7.1.1 Europe Gengnian An Tablets Sales by Country (2021-2026)
  7.1.2 Europe Gengnian An Tablets Revenue by Country (2021-2026)
7.2 Europe Gengnian An Tablets Sales by Type (2021-2026)
7.3 Europe Gengnian An Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gengnian An Tablets by Country
  8.1.1 Middle East & Africa Gengnian An Tablets Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Gengnian An Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Gengnian An Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Gengnian An Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gengnian An Tablets
10.3 Manufacturing Process Analysis of Gengnian An Tablets
10.4 Industry Chain Structure of Gengnian An Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Gengnian An Tablets Distributors
11.3 Gengnian An Tablets Customer

12 WORLD FORECAST REVIEW FOR GENGNIAN AN TABLETS BY GEOGRAPHIC REGION

12.1 Global Gengnian An Tablets Market Size Forecast by Region
  12.1.1 Global Gengnian An Tablets Forecast by Region (2027-2032)
  12.1.2 Global Gengnian An Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Gengnian An Tablets Forecast by Type (2027-2032)
12.7 Global Gengnian An Tablets Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Lanzhou Taibao Pharmaceutical Co., Ltd.
  13.1.1 Lanzhou Taibao Pharmaceutical Co., Ltd. Company Information
  13.1.2 Lanzhou Taibao Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.1.3 Lanzhou Taibao Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Lanzhou Taibao Pharmaceutical Co., Ltd. Main Business Overview
  13.1.5 Lanzhou Taibao Pharmaceutical Co., Ltd. Latest Developments
13.2 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd.
  13.2.1 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Company Information
  13.2.2 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.2.3 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Main Business Overview
  13.2.5 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Latest Developments
13.3 Tianjin Medicine Darentang Group Co., Ltd.
  13.3.1 Tianjin Medicine Darentang Group Co., Ltd. Company Information
  13.3.2 Tianjin Medicine Darentang Group Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.3.3 Tianjin Medicine Darentang Group Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Tianjin Medicine Darentang Group Co., Ltd. Main Business Overview
  13.3.5 Tianjin Medicine Darentang Group Co., Ltd. Latest Developments
13.4 Xi'an Zili Chinese Medicine Group Co., Ltd.
  13.4.1 Xi'an Zili Chinese Medicine Group Co., Ltd. Company Information
  13.4.2 Xi'an Zili Chinese Medicine Group Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.4.3 Xi'an Zili Chinese Medicine Group Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Xi'an Zili Chinese Medicine Group Co., Ltd. Main Business Overview
  13.4.5 Xi'an Zili Chinese Medicine Group Co., Ltd. Latest Developments
13.5 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  13.5.1 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information
  13.5.2 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.5.3 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Main Business Overview
  13.5.5 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Latest Developments
13.6 Yabao Pharmaceutical Group Co., Ltd.
  13.6.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  13.6.2 Yabao Pharmaceutical Group Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.6.3 Yabao Pharmaceutical Group Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Yabao Pharmaceutical Group Co., Ltd. Main Business Overview
  13.6.5 Yabao Pharmaceutical Group Co., Ltd. Latest Developments
13.7 Guilong Pharmaceutical (Anhui) Co., Ltd.
  13.7.1 Guilong Pharmaceutical (Anhui) Co., Ltd. Company Information
  13.7.2 Guilong Pharmaceutical (Anhui) Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.7.3 Guilong Pharmaceutical (Anhui) Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Guilong Pharmaceutical (Anhui) Co., Ltd. Main Business Overview
  13.7.5 Guilong Pharmaceutical (Anhui) Co., Ltd. Latest Developments
13.8 Jilin Zixin Pharmaceutical Co., Ltd.
  13.8.1 Jilin Zixin Pharmaceutical Co., Ltd. Company Information
  13.8.2 Jilin Zixin Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.8.3 Jilin Zixin Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Jilin Zixin Pharmaceutical Co., Ltd. Main Business Overview
  13.8.5 Jilin Zixin Pharmaceutical Co., Ltd. Latest Developments
13.9 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd.
  13.9.1 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Company Information
  13.9.2 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.9.3 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Main Business Overview
  13.9.5 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Latest Developments
13.10 Guangxi Jinhaitang Pharmaceutical Co., Ltd.
  13.10.1 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Company Information
  13.10.2 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.10.3 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Main Business Overview
  13.10.5 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Latest Developments
13.11 Shanxi Zhendong Pharmaceutical Co., Ltd.
  13.11.1 Shanxi Zhendong Pharmaceutical Co., Ltd. Company Information
  13.11.2 Shanxi Zhendong Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.11.3 Shanxi Zhendong Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Shanxi Zhendong Pharmaceutical Co., Ltd. Main Business Overview
  13.11.5 Shanxi Zhendong Pharmaceutical Co., Ltd. Latest Developments
13.12 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  13.12.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
  13.12.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.12.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Main Business Overview
  13.12.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Latest Developments
13.13 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
  13.13.1 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information
  13.13.2 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolios and Specifications
  13.13.3 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Main Business Overview
  13.13.5 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Gengnian AnTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Gengnian AnTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sugar-coatedTablets
Table 4. Major Players of Non-sugar-coatedTablets
Table 5. Global Gengnian AnTablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Gengnian AnTablets Sales Market Share by Type (2021-2026)
Table 7. Global Gengnian AnTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Gengnian AnTablets Revenue Market Share by Type (2021-2026)
Table 9. Global Gengnian AnTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Gengnian AnTablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Gengnian AnTablets Sale Market Share by Application (2021-2026)
Table 12. Global Gengnian AnTablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Gengnian AnTablets Revenue Market Share by Application (2021-2026)
Table 14. Global Gengnian AnTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Gengnian AnTablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Gengnian AnTablets Sales Market Share by Company (2021-2026)
Table 17. Global Gengnian AnTablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Gengnian AnTablets Revenue Market Share by Company (2021-2026)
Table 19. Global Gengnian AnTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Gengnian AnTablets Producing Area Distribution and Sales Area
Table 21. Players Gengnian AnTablets Products Offered
Table 22. Gengnian AnTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Gengnian AnTablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Gengnian AnTablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Gengnian AnTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Gengnian AnTablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Gengnian AnTablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Gengnian AnTablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Gengnian AnTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Gengnian AnTablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Gengnian AnTablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Gengnian AnTablets Sales Market Share by Country (2021-2026)
Table 35. Americas Gengnian AnTablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Gengnian AnTablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Gengnian AnTablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Gengnian AnTablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Gengnian AnTablets Sales Market Share by Region (2021-2026)
Table 40. APAC Gengnian AnTablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Gengnian AnTablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Gengnian AnTablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Gengnian AnTablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Gengnian AnTablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Gengnian AnTablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Gengnian AnTablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Gengnian AnTablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Gengnian AnTablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Gengnian AnTablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Gengnian AnTablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Gengnian AnTablets
Table 52. Key Market Challenges & Risks of Gengnian AnTablets
Table 53. Key Industry Trends of Gengnian AnTablets
Table 54. Gengnian AnTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Gengnian AnTablets Distributors List
Table 57. Gengnian AnTablets Customer List
Table 58. Global Gengnian AnTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Gengnian AnTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Gengnian AnTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Gengnian AnTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Gengnian AnTablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Gengnian AnTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Gengnian AnTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Gengnian AnTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Gengnian AnTablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Gengnian AnTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Gengnian AnTablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Gengnian AnTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Gengnian AnTablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Gengnian AnTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Lanzhou Taibao Pharmaceutical Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Lanzhou Taibao Pharmaceutical Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 74. Lanzhou Taibao Pharmaceutical Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Lanzhou Taibao Pharmaceutical Co., Ltd. Main Business
Table 76. Lanzhou Taibao Pharmaceutical Co., Ltd. Latest Developments
Table 77. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 79. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Main Business
Table 81. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Latest Developments
Table 82. Tianjin Medicine Darentang Group Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Tianjin Medicine Darentang Group Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 84. Tianjin Medicine Darentang Group Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Tianjin Medicine Darentang Group Co., Ltd. Main Business
Table 86. Tianjin Medicine Darentang Group Co., Ltd. Latest Developments
Table 87. Xi'an Zili Chinese Medicine Group Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Xi'an Zili Chinese Medicine Group Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 89. Xi'an Zili Chinese Medicine Group Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Xi'an Zili Chinese Medicine Group Co., Ltd. Main Business
Table 91. Xi'an Zili Chinese Medicine Group Co., Ltd. Latest Developments
Table 92. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 94. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Main Business
Table 96. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Latest Developments
Table 97. Yabao Pharmaceutical Group Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Yabao Pharmaceutical Group Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 99. Yabao Pharmaceutical Group Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Yabao Pharmaceutical Group Co., Ltd. Main Business
Table 101. Yabao Pharmaceutical Group Co., Ltd. Latest Developments
Table 102. Guilong Pharmaceutical (Anhui) Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Guilong Pharmaceutical (Anhui) Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 104. Guilong Pharmaceutical (Anhui) Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Guilong Pharmaceutical (Anhui) Co., Ltd. Main Business
Table 106. Guilong Pharmaceutical (Anhui) Co., Ltd. Latest Developments
Table 107. Jilin Zixin Pharmaceutical Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Jilin Zixin Pharmaceutical Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 109. Jilin Zixin Pharmaceutical Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Jilin Zixin Pharmaceutical Co., Ltd. Main Business
Table 111. Jilin Zixin Pharmaceutical Co., Ltd. Latest Developments
Table 112. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 114. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Main Business
Table 116. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Latest Developments
Table 117. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 119. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Main Business
Table 121. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Latest Developments
Table 122. Shanxi Zhendong Pharmaceutical Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanxi Zhendong Pharmaceutical Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 124. Shanxi Zhendong Pharmaceutical Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Shanxi Zhendong Pharmaceutical Co., Ltd. Main Business
Table 126. Shanxi Zhendong Pharmaceutical Co., Ltd. Latest Developments
Table 127. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 128. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 129. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Main Business
Table 131. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Latest Developments
Table 132. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Basic Information, Gengnian AnTablets Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Gengnian AnTablets Product Portfolios and Specifications
Table 134. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Gengnian AnTablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Main Business
Table 136. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Gengnian AnTablets
Figure 2. Gengnian AnTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gengnian AnTablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Gengnian AnTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Gengnian AnTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Gengnian AnTablets Sales Market Share by Country/Region (2025)
Figure 10. Gengnian AnTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sugar-coatedTablets
Figure 12. Product Picture of Non-sugar-coatedTablets
Figure 13. Global Gengnian AnTablets Sales Market Share by Type in 2026
Figure 14. Global Gengnian AnTablets Revenue Market Share by Type (2021-2026)
Figure 15. Gengnian AnTablets Consumed in Hospital
Figure 16. Global Gengnian AnTablets Market: Hospital (2021-2026) & (K Units)
Figure 17. Gengnian AnTablets Consumed in Clinic
Figure 18. Global Gengnian AnTablets Market: Clinic (2021-2026) & (K Units)
Figure 19. Gengnian AnTablets Consumed in Other
Figure 20. Global Gengnian AnTablets Market: Other (2021-2026) & (K Units)
Figure 21. Global Gengnian AnTablets Sale Market Share by Application (2025)
Figure 22. Global Gengnian AnTablets Revenue Market Share by Application in 2026
Figure 23. Gengnian AnTablets Sales by Company in 2026 (K Units)
Figure 24. Global Gengnian AnTablets Sales Market Share by Company in 2026
Figure 25. Gengnian AnTablets Revenue by Company in 2026 ($ millions)
Figure 26. Global Gengnian AnTablets Revenue Market Share by Company in 2026
Figure 27. Global Gengnian AnTablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Gengnian AnTablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Gengnian AnTablets Sales 2021-2026 (K Units)
Figure 30. Americas Gengnian AnTablets Revenue 2021-2026 ($ millions)
Figure 31. APAC Gengnian AnTablets Sales 2021-2026 (K Units)
Figure 32. APAC Gengnian AnTablets Revenue 2021-2026 ($ millions)
Figure 33. Europe Gengnian AnTablets Sales 2021-2026 (K Units)
Figure 34. Europe Gengnian AnTablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Gengnian AnTablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Gengnian AnTablets Revenue 2021-2026 ($ millions)
Figure 37. Americas Gengnian AnTablets Sales Market Share by Country in 2026
Figure 38. Americas Gengnian AnTablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas Gengnian AnTablets Sales Market Share by Type (2021-2026)
Figure 40. Americas Gengnian AnTablets Sales Market Share by Application (2021-2026)
Figure 41. United States Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Gengnian AnTablets Sales Market Share by Region in 2026
Figure 46. APAC Gengnian AnTablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC Gengnian AnTablets Sales Market Share by Type (2021-2026)
Figure 48. APAC Gengnian AnTablets Sales Market Share by Application (2021-2026)
Figure 49. China Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Gengnian AnTablets Sales Market Share by Country in 2026
Figure 57. Europe Gengnian AnTablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe Gengnian AnTablets Sales Market Share by Type (2021-2026)
Figure 59. Europe Gengnian AnTablets Sales Market Share by Application (2021-2026)
Figure 60. Germany Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Gengnian AnTablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Gengnian AnTablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Gengnian AnTablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Gengnian AnTablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Gengnian AnTablets in 2026
Figure 74. Manufacturing Process Analysis of Gengnian AnTablets
Figure 75. Industry Chain Structure of Gengnian AnTablets
Figure 76. Channels of Distribution
Figure 77. Global Gengnian AnTablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global Gengnian AnTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Gengnian AnTablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Gengnian AnTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Gengnian AnTablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Gengnian AnTablets Revenue Market Share Forecast by Application (2027-2032)


More Publications